UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________________

FORM 8-K

Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 30, 2015

AIR METHODS CORPORATION
(Exact name of Registrant as Specified in Its Charter)

Delaware
0-16079
84-0915893
(State or other jurisdiction of incorporation or organization)
(Commission file number)
(IRS Employer Identification Number)

7301 South Peoria, Englewood, Colorado
 
80112
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code: (303) 792-7400

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 30, 2015, the Board of Directors (the “Board”) of Air Methods Corporation (the “Company”), based upon a recommendation of the nominating and corporate governance committee of the Board, elected Claire M. Gulmi to serve as a director of the Company, effective immediately. Ms. Gulmi will serve as a Class III director, with her initial term expiring at the Company’s 2015 annual meeting of stockholders to be held in May 2015. Ms. Gulmi will serve on the audit committee of the Board.

Ms. Gulmi will receive the pro rata portion of the annual retainer for service on the Board (currently $75,550 per annum), based on the number of days remaining in the current director compensation year. In addition, she has received a restricted stock grant of 1,016 shares and an option grant of 6,980 shares which is a pro rata portion of the annual grants awarded to each of our non-employee directors in January 2015.

There is no arrangement or understanding pursuant to which Ms. Gulmi was appointed as a director. Further, Ms. Gulmi has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

A press release announcing Ms. Gulmi’s appointment is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) The following exhibit is filed as part of this report:

99.1 Press Release dated April 1, 2015
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
AIR METHODS CORPORATION
     
Date: April 3, 2015
By:
/s/ Crystal L. Gordon
   
Crystal L. Gordon, General Counsel and Secretary

 






Exhibit 99.1
 


Claire Gulmi Joins Air Methods’ Board of Directors;
Dr. Lowell Miller to Retire

DENVER, April 1, 2015 Air Methods Corporation (Nasdaq: AIRM), the global leader in air medical transportation, today announced that Claire M. Gulmi, Chief Financial Officer of AmSurg Corp., has been elected to the Air Methods’ board of directors. Ms. Gulmi will be replacing Dr. Lowell Miller, one the board’s long-serving members. Dr. Miller will retire immediately before the 2015 Annual Stockholder Meeting after 25 years of service. Ms. Gulmi will serve on the Company’s Audit Committee. Her appointment was effective March 30, 2015.

Ms. Gulmi is a seasoned health care executive with 20 years of experience as Chief Financial Officer of AmSurg Corp., a nationally recognized leader in development, management and operation of outpatient surgery centers. During Ms. Gulmi’s tenure, she has overseen, among other things, a growth in revenue from $30 million to over $1.62 billion and recently helped orchestrate AmSurg’s acquisition of Sheridan Healthcare (valued at approximately $2.35 billion).

“Claire’s strong financial background coupled with her expertise in the evolving health care industry will make her a key asset to the board. We are excited to welcome her to Air Methods,” said Aaron Todd, chief executive officer, Air Methods.

“We committed a thoughtful search process for a new director and we are delighted to have identified such an outstanding individual. We fully expect that Claire will have an important and positive impact on Air Methods,” said David C. Kikumoto, chairman of the board, Air Methods. Kikumoto also added, “On behalf of the board of directors, we wanted to take this opportunity to thank Lowell for his leadership and friendship over the last 25 years. He will be missed.”

Air Methods Corporation (www.airmethods.com) is the global leader in air medical transportation. The Air Medical Services Division is the largest provider of air medical transport services in the United States. The United Rotorcraft Division specializes in the design and manufacture of aeromedical and aerospace technology. The Tourism Division is comprised of Sundance Helicopters, Inc. and Blue Hawaiian Helicopters, which provides helicopter tours and charter flights in the Las Vegas/Grand Canyon region and Hawaii, respectively. Air Methods’ fleet of owned, leased or maintained aircraft features over 450 helicopters and fixed wing aircraft.



CONTACTS: Christina Brodsly, Director, Corporate Communications (303) 256-4122 or christina.brodsly@airmethods.com. Please contact Christina to be included on the company’s e-mail distribution list.
 
 


Air Methods Corp. (NASDAQ:AIRM)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Air Methods Corp. Charts.
Air Methods Corp. (NASDAQ:AIRM)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Air Methods Corp. Charts.